Clinical Research Peptide Documentation Checklist
An audit-ready peptide lot requires six documents before it enters inventory: a batch-specific Certificate of Analysis (COA), HPLC chromatogram, LC-MS identity report, Safety Data Sheet (SDS), packing list, and a storage/handling statement. The single most critical action is reconciling the batch number across all five locations: COA, HPLC report, LC-MS report, vial label, and packing slip. Without that reconciliation, no amount of clean-looking paperwork satisfies an FDA 21 CFR Part 11 audit trail or the ALCOA+ standard for attributable, contemporaneous records. PeptidesFromChina structures its supplier packages around exactly this requirement.
Must-have records at receipt:
Batch-specific COA (lot number, date of analysis, method references, acceptance criteria)
HPLC chromatogram with peak integration and LC-MS mass confirmation (observed vs. theoretical)
SDS, packing list, and written storage/handling statement
Pro Tip: Treat the receiving file for every RUO peptide lot the way a clinical trial site treats its Regulatory Binder: every document that could reconstruct the material’s lifecycle should be present before the vial moves off the receiving bench.
Table of Contents
What does a 30-second receiving checklist look like?
How do you verify a peptide lot before accepting it into inventory?
What documents should you request from suppliers?
How should you document receiving, temperature logs, and chain of custody?
How do you manage document control and retention for audit readiness?
What documentation failures should you watch for?
What templates and forms does a receiving team need?
Key Takeaways
The documentation gap most procurement teams underestimate
PeptidesFromChina provides batch-specific documentation for procurement teams
Useful sources and recommended reading
What does a 30-second receiving checklist look like?
Use this at the dock or cold-room door before signing for any peptide shipment.
Confirm outer packaging is intact; note any damage or temperature indicator status.
Match packing list to purchase order: product name, quantity, and lot number.
Locate the COA and verify the batch number matches the vial label exactly.
Confirm HPLC chromatogram and LC-MS report are present and reference the same lot.
Check that an SDS is included and that storage temperature instructions are stated.
Initial and date each document in the receiving file.
If any batch number mismatches or documents are missing, quarantine the lot immediately and escalate to QA before proceeding.
Pro Tip: Print this checklist and laminate one copy for the receiving bench. Staff should initial step 6 in ink, not digitally, unless your ELN captures a date-stamped electronic signature compliant with 21 CFR Part 11.
How do you verify a peptide lot before accepting it into inventory?
Pre-acceptance verification is a reproducible sequence, not a spot check. Following it consistently prevents the retroactive corrective actions that break traceability and complicate grant reporting.
Verify identity on the manifest and COA. Confirm the product name, sequence or form, and RUO intended-use statement. If the COA lacks an RUO declaration, flag it for institutional compliance review before acceptance.
Reconcile batch numbers across five locations. Cross-reference the lot number on the COA, HPLC report, LC-MS report, vial label, and packing list. Batch number reconciliation across all five is the most common audit failure point. Document the reconciliation in a COA reconciliation log with the reviewer’s initials and date.
Confirm analytical support. The HPLC chromatogram must show peak integration data. The LC-MS report must state observed versus theoretical mass. Both must cite the analytical method used.
Photo-capture the receiving evidence. Photograph the vial label, COA batch number, and packing slip together in a single frame. Store time-stamped images in the regulatory binder or ELN entry for that lot.
Quarantine if mismatches exist. Any discrepancy triggers immediate hold status. A secondary QA reviewer must sign off before the lot is released.
Pro Tip: Complete verification before the inventory entry, not after. Retroactive corrections require deviation records, secondary sign-off, and explanatory notes that consume far more time than the original check.
Batch-specific HPLC and LC-MS packages are the minimum standard for labs that need reproducible results or must support grant evidence.
A photo record of vial plus COA plus packing slip, time-stamped, closes most traceability gaps at minimal cost.
What documents should you request from suppliers?
Supplier qualification starts with the document request, not the shipment. Request the following before placing any order:
Batch-specific COA (lot number, date of analysis, method references, and acceptance criteria stated explicitly)
HPLC chromatogram for that batch, with peak integration
LC-MS raw data confirming observed vs. theoretical mass
Specification sheet (sequence, molecular weight, purity threshold, salt form)
SDS
Packing list template showing how lot numbers will appear
Certificate of origin where applicable
Dangerous goods declaration if the shipment includes dry ice or express courier cold-chain
A COA without a batch number has limited traceability value. Representative COAs covering a product line rather than a specific lot are insufficient for internal audits or grant reporting. Require batch-specific packages in writing before the purchase order is issued.
When to require third-party testing: during initial supplier qualification, or any time the supplier’s own analytics are incomplete or the lot will support a publication or IND-adjacent study. For routine reorders from a qualified supplier with a clean track record, representative data may be acceptable as a secondary check, but batch-specific COA and HPLC remain the baseline. See the vendor qualification criteria guide for a full scoring framework.
Pro Tip: Ask suppliers to include the analytical method reference (e.g., RP-HPLC at 220 nm, ESI-MS) directly on the COA. A purity percentage with no method citation cannot be verified or replicated.
Document Minimum Requirement Red Flag COA Batch number, date, method, acceptance criteria No lot number; generic or representative only HPLC chromatogram Peak integration, batch-matched Purity % stated without chromatogram LC-MS report Observed vs. theoretical mass, batch-matched Missing or undated SDS Current revision, product-specific Generic or missing Specification sheet Sequence, MW, purity threshold, salt form Absent or inconsistent with COA
How should you document receiving, temperature logs, and chain of custody?
Physical receipt documentation runs parallel to the analytical verification above. Both must be complete before a lot is released from quarantine.
Receiving inspection steps:
Match packing list line items to purchase order quantities and lot numbers.
Inspect outer and inner seals; photograph any damage.
Check temperature indicator or data logger output. For lyophilized peptides, acceptable transit temperature is typically 2°C–8°C or ambient depending on supplier specification; refrigerated peptides require confirmed cold-chain continuity.
Record arrival condition, storage location assigned, and the name and initials of the receiving technician.
Chain-of-Custody Field Required Entry Received by Name, role, initials Date and time Timestamp at receipt Lot number Must match COA and vial Condition on arrival Intact / damaged / temperature excursion noted Storage location assigned Freezer ID, shelf, position Transfer sign-off Initials of each custody transfer point
Temperature excursion decision tree: if the data logger shows a deviation outside the stated range, quarantine immediately, document the excursion with logger output attached, and contact the supplier for disposition guidance. Do not release the lot until QA reviews the excursion record and issues a written disposition decision.
Pro Tip: Attach the data logger printout or exported CSV directly to the chain-of-custody form in the regulatory binder. A verbal note that “it arrived cold” is not a document.
How do you manage document control and retention for audit readiness?
The Regulatory Binder for RUO materials should mirror the structure of a clinical trial essential records file: every document that could reconstruct the material’s lifecycle must be present, organized, and retrievable. File COAs, analytical packages, receiving logs, ELN links, deviation records, and supplier qualification files in clearly labeled sections.
Peer review and sign-off: ALCOA+ documentation standards require a secondary reviewer to confirm accuracy and approvals with date stamps. Every receiving record and deviation log entry should carry two sets of initials: the originator and the reviewer, with dates for both.
Version control: finalize documents as PDFs with access controls. Electronic records used in trial contexts must support audit trails; where 21 CFR Part 11 applies, the system must be validated to ensure functionality, as detailed in The Enrollment Problem: How AI Is Closing the Gap Between Protocol Design and Patient Recruitment. EMA guidance indicates archiving periods of at least 25 years for some trial records. For RUO research, align retention periods with your institution’s policy, but a minimum of study closeout plus five years is a defensible baseline for most US research settings.
Document Type Storage Location Retention Trigger Batch-specific COA Regulatory Binder, Section 2 Study closeout + institutional minimum HPLC / LC-MS package Regulatory Binder, Section 2 Study closeout + institutional minimum Receiving and chain-of-custody log Regulatory Binder, Section 3 Study closeout + institutional minimum Deviation records Regulatory Binder, Section 5 Study closeout + institutional minimum Supplier qualification file Regulatory Binder, Section 1 Last purchase + institutional minimum
Pro Tip: Link ELN entries to the corresponding regulatory binder section by lot number. When an auditor asks for the analytical package for a specific experiment, the retrieval path should take seconds, not hours.
What documentation failures should you watch for?
The most common gaps, and what each signals:
Missing COA entirely: supplier cannot demonstrate batch traceability.
COA present but no batch number: the certificate cannot be linked to the specific vial received.
HPLC purity percentage stated without a chromatogram: the claim is unverifiable.
Vial label lot number differs from COA lot number: the material’s identity is unconfirmed.
Documents provided only after payment: supplier is not prepared to support pre-acceptance review.
Documentation in an unreadable language with no translation: cannot satisfy ALCOA+ legibility requirements.
Corrective action sequence when a red flag appears:
Place the lot in quarantine immediately; do not enter it into inventory.
Document the discrepancy in the deviation log with a timestamp and your initials.
Escalate to QA for secondary review within one business day.
Contact the supplier with a written request for the missing or corrected document, specifying a response SLA.
QA issues a written disposition: accept, accept with limitation, or reject.
File the deviation log entry, supplier correspondence, and disposition decision together in the regulatory binder.
Accepting a mismatched lot without a documented disposition creates a traceability gap that surfaces during audits, complicates grant reporting, and can invalidate publication reproducibility claims. The corrective action cost of a retroactive fix is almost always higher than the delay of a proper hold.
What templates and forms does a receiving team need?
A complete receiving template set covers five documents:
Incoming inspection form (printable, with fields for lot number, condition, temperature, and receiving technician initials)
COA reconciliation log (spreadsheet with columns for lot number, COA date, HPLC match, LC-MS match, vial label match, packing slip match, and reviewer sign-off)
Chain-of-custody form (as detailed in the receiving section above)
Deviation log snippet (date, description, lot number, corrective action, QA sign-off)
Receiving SOP snippet (one-page procedure referencing the checklist steps above)
Store finalized forms as PDFs in the regulatory binder. Use CSV or Excel for the COA reconciliation log so records can be sorted and filtered by lot number or date. Link ELN entries to the corresponding PDF by lot number.
Document Preferred Format Regulatory Binder Section Incoming inspection form Fillable PDF Section 3 COA reconciliation log CSV / Excel Section 2 Chain-of-custody form Fillable PDF Section 3 Deviation log Fillable PDF Section 5 Supplier qualification file PDF package Section 1
Pro Tip: Version-control the blank templates themselves. When an auditor asks which version of the inspection form was in use during a specific study period, you need to be able to answer that question from the file, not from memory.
Key Takeaways
An audit-ready peptide receiving program requires batch-number reconciliation across five documents, photo evidence at receipt, secondary peer-review sign-off, and a regulatory binder that can reconstruct every lot’s lifecycle on demand.
Point Details COA-to-vial reconciliation Match the lot number across COA, HPLC, LC-MS, vial label, and packing slip before any inventory entry. Photo evidence at receipt A time-stamped photo of vial, COA, and packing slip together closes most traceability gaps at minimal effort. Secondary peer-review sign-off Every receiving record and deviation entry needs two sets of dated initials to satisfy ALCOA+ standards. Regulatory Binder structure File COAs, analytical packages, receiving logs, and deviation records in labeled sections with defined retention triggers. PeptidesFromChina sourcing PeptidesFromChina provides batch-specific COAs and options for independent analytical packages, supporting audit-ready procurement from the first order.
The documentation gap most procurement teams underestimate
The standard advice is to “request a COA.” That is the floor, not the ceiling. What most receiving teams discover too late is that a COA without a matching chromatogram, or a chromatogram without a confirmed lot number, creates a documentation gap that looks fine until an auditor or grant reviewer asks a specific question about a specific lot. At that point, the gap is not fixable retroactively without a deviation record and a secondary sign-off, both of which raise more questions than they answer.
The more useful framing is to treat every peptide lot as a potential audit exhibit from the moment it arrives. That means the photo record, the reconciliation log, and the chain-of-custody form are not bureaucratic overhead. They are the evidence that the material in the experiment is the material described in the COA. Without that chain, reproducibility is an assertion, not a documented fact.
Independent third-party testing deserves more weight during supplier qualification than most teams give it. When a supplier’s own analytics are the only verification, the procurement team is relying on the supplier to audit itself. For mission-critical studies, budget for at least one independent verification cycle per new supplier, and negotiate the SLA into the procurement contract before the first order ships. The supplier vetting checklist covers the scoring criteria in detail.
Training matters more than the template. A well-designed receiving form captures nothing if the technician filling it out does not understand why each field exists. A short onboarding session covering the COA reconciliation logic and the quarantine decision tree pays for itself the first time a mismatched lot is caught before it enters inventory.
PeptidesFromChina provides batch-specific documentation for procurement teams
Research teams that need guaranteed documentation packages before a lot ships have a direct option. PeptidesFromChina sources directly from established synthesis facilities and provides batch-specific COAs as standard, with options to request independent analytical packages including HPLC chromatograms and LC-MS confirmation data for specific lots.
To request a documentation package, contact the procurement team with the SKU, required lot linkage, and the analytic types needed (HPLC, LC-MS, or both). Expected turnaround for documentation delivery is confirmed at the time of stock verification. Teams that require guaranteed analytic packages and expedited handling can access the VIP procurement option, which is structured for labs with defined documentation SLAs. Browse the full research peptide catalog to identify SKUs and submit a sourcing request with your batch documentation requirements included from the first inquiry.
Useful sources and recommended reading
Primary references for procurement teams building or defending documentation policy in US research settings:
Essential Documents & Essential Records (UNC Clinical Research): the authoritative US academic playbook for Regulatory Binder structure and GCP-aligned recordkeeping; cite this when writing institutional SOPs.
Good Documentation Practices (IMPAACT Network): the clearest available reference for ALCOA+ requirements, peer-review sign-off standards, and version control; file a copy in the regulatory binder’s policy section.
Trial Records Guidance (Clinical Trials Toolkit): EMA-aligned archiving and electronic TMF validation guidance; useful for labs with international collaborators or those planning IND-adjacent studies.
ICH E6(R3) Good Clinical Practice: the governing GCP standard for essential records management; reference this when institutional policy requires GCP alignment for RUO materials.
Regulatory Guidelines for Therapeutic Peptides and Proteins (PMC): covers ICH Q6B, Q1A(R2), and analytical method validation requirements for peptide characterization; useful background for teams specifying acceptance criteria on COAs.
Research-Grade Peptide Shipment Documents Checklist (WUMO Peptide): practical checklist covering the core document set and batch reconciliation logic; use as a secondary reference when training receiving staff.
RUO Peptide Documentation Checklist (PurePep Vital): covers intended-use labeling, batch-specific analytics, and independent verification guidance for RUO procurement.
When citing these sources in institutional SOPs, include the document title, URL, and access date. File a PDF snapshot of each reference in the regulatory binder’s policy section so the version consulted during SOP development is preserved even if the source URL changes.